When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount
It may be considered as part of specialist weight management services for eligible patients with a BMI of 35 kg/m or above (or lower thresholds for people from certain ethnic groups) with at least one weight-related comorbidity
Gastrointestinal symptoms are the most common manifestations of tirzepatide overdose and may include: Severe nausea and vomiting : Often persistent and more intense than typical side effects, potentially leading to inability to retain fluids or medications Abdominal pain or cramping : May range from mild discomfort to severe pain, typically in the upper abdomen Diarrhea : Can contribute to dehydration and electrolyte imbalances Loss of appetite : Complete aversion to food, extending beyond normal appetite suppression Metabolic disturbances requiring medical attention: Hypoglycemia : Symptoms include trembling, sweating, rapid heartbeat, confusion, dizziness, hunger, irritability, and in severe cases, loss of consciousness or seizures
Instead, it can be a reaction as your body rapidly loses weight from the treatment
